You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Nitrofurazone - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for nitrofurazone and what is the scope of patent protection?

Nitrofurazone is the generic ingredient in three branded drugs marketed by Shire, Sherwood Medcl, Ambix, Lannett, Perrigo New York, Taro, and Wendt, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for nitrofurazone.

Summary for nitrofurazone
Recent Clinical Trials for nitrofurazone

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
James Graham Brown Cancer CenterEarly Phase 1
Julio RamirezEarly Phase 1
University of LouisvilleEarly Phase 1

See all nitrofurazone clinical trials

Medical Subject Heading (MeSH) Categories for nitrofurazone

US Patents and Regulatory Information for nitrofurazone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire FURACIN nitrofurazone POWDER;TOPICAL 083791-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wendt NITROFURAZONE nitrofurazone SOLUTION;TOPICAL 087081-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wendt NITROFURAZONE nitrofurazone OINTMENT;TOPICAL 086766-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sherwood Medcl ACTIN-N nitrofurazone DRESSING;TOPICAL 017343-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Perrigo New York NITROFURAZONE nitrofurazone OINTMENT;TOPICAL 084968-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro NITROFURAZONE nitrofurazone OINTMENT;TOPICAL 086156-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.